Clinical Trials Logo

Anemia, Iron Deficiency clinical trials

View clinical trials related to Anemia, Iron Deficiency.

Filter by:
  • Withdrawn  
  • Page 1 ·  Next »

NCT ID: NCT05927012 Withdrawn - Clinical trials for Iron Deficiency Anemia

A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).

Start date: November 30, 2023
Phase: Phase 2
Study type: Interventional

This study aims to explore the safety and preliminary efficacy of a response-guided dose titration of KER-047 in the treatment of functional IDA (Iron deficiency anemia) in MDS (Myelodysplastic syndrome), MF(Myelofibrosis), and MDS/MPN (Myeloproliferative neoplasm) overlap syndromes.

NCT ID: NCT05073562 Withdrawn - Clinical trials for Knowledge, Attitudes, Practice

Nutrition Intervention to Address Anemia Among Adolescent Girls in Liberia

Start date: October 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the feasibility and effectiveness of weekly iron and folic acid (IFA) supplementation and one-time deworming treatment at the community level in improving hemoglobin levels among adolescent girls in Liberia, West Africa, and to assess the feasibility and effectiveness of a targeted nutrition education program in improving nutrition knowledge, attitudes, and practices in the same population.

NCT ID: NCT04968379 Withdrawn - Clinical trials for Iron Deficiency, Anaemia

Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia

Start date: July 21, 2022
Phase: Phase 2
Study type: Interventional

An Open-Label, Multi-Center Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous Ferric Carboxymaltose (FCM) in Infants (0-1 year) with Iron Deficiency Anemia.

NCT ID: NCT04855266 Withdrawn - Iron-deficiency Clinical Trials

Iron Sucrose in Patients With Iron Deficiency and POTS

Start date: April 2021
Phase: Phase 2
Study type: Interventional

This study aims to investigate whether the treatment of non-anemic iron deficiency with intravenous iron sucrose will result in decreased symptom reporting and improved cardiovascular indices in patients with Postural Orthostatic Tachycardia syndrome (POTS).

NCT ID: NCT04320966 Withdrawn - Anemia Clinical Trials

Neurovascular Complications and White Matter Damage in Acquired Anemias

Start date: November 1, 2020
Phase:
Study type: Observational

This is an observational trial, in patients with moderate to severe anemia and control subjects. The main purpose of this study is to understand whether normal brain blood flow, oxygen extraction reserve, white matter volumes, and brain functional connectivity are affected by acquired anemia. The investigators will perform baseline MRI monitoring for all subjects. All eligible subjects will be asked to provide informed consent before participating in the study.

NCT ID: NCT03944733 Withdrawn - Clinical trials for Iron Deficiency Anemia

Iron Status, Maternal Depressive Symptoms, and Mother-child Interactions

IDinteract
Start date: December 1, 2019
Phase: N/A
Study type: Interventional

This study aims to examine the relation between iron status and maternal-child interactions as well as maternal depressive symptoms in mothers from central Pennsylvania.

NCT ID: NCT03873584 Withdrawn - Anemia Clinical Trials

Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy

IFAISTOS
Start date: September 1, 2022
Phase:
Study type: Observational

The treatment of anemia depends on its cause. Patients with underlying iron-deficient anemia should be treated or referred to a specialist (eg gynecologist, gastroenterologist) for treatment.deficiency anemia are global health problems and common medical conditions seen in everyday clinical practice. Iron is vital for biological functions, such as breathing, energy production, DNA synthesis, and cell proliferation. Iron deficiency refers to the reduction of iron stores and precedes the occurrence of iron deficiency anemia. Iron deficiency anemia is a more severe condition in which low levels of iron are associated with anemia and the presence of small cellular red blood cells.

NCT ID: NCT03873571 Withdrawn - Pregnancy Related Clinical Trials

Adherence of Iron Succinylate Therapy in Pregnancy

ARTEMIS
Start date: December 30, 2022
Phase:
Study type: Observational

According to the World Health Organization (WHO), anemia is the most common disease, affecting >1.5 billion people worldwide. Furthermore, iron deficiency anemia (IDA) accounts for 50% of cases of anemia. IDA is common during pregnancy and the postpartum period, and can lead to serious maternal and fetal complications. Measurement of serum ferritin has the highest sensitivity and specificity for diagnosis of IDA unless there is a concurrent inflammatory condition. The lower threshold value for hemoglobin (Hb) in pregnant women is <11 g/dL during the 1st and 3rd trimesters, and <10.5 g/dL during the 2nd trimester. In postpartum period a Hb concentration <10 g/dL indicates clinically significant anemia. Oral iron therapy is given as the first-line treatment for IDA.

NCT ID: NCT03803111 Withdrawn - Clinical trials for Heart Failure With Reduced Ejection Fraction

Effects of Iron Therapy and Exercise Training in Patients With Heart Failure and Iron Deficiency

IronEx
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

It is the aim of the study to prove, if intravenous supplementation with ferric carboxymaltose in iron-deficient patients with heart failure with reduced ejection fraction (HFrEF) leads to better exercise training effects compared to exercise training without previous iron supplementation.

NCT ID: NCT03800446 Withdrawn - Iron-deficiency Clinical Trials

Validation of a Point-of-care Device Measuring Ferritin With Capillary Blood

FerPOC
Start date: September 2019
Phase: N/A
Study type: Interventional

Measurement of iron is important for identifying both low and high iron levels in the body. Measuring a protein in the blood called ferritin is currently the easiest way to determine a patient's iron status. However, the test requires a blood sample that is be sent to the laboratory for measurement, which can cause delays in obtaining the result. The investigators are testing whether a point of care device that measures ferritin levels using a capillary blood sample is accurate compared to current methods of testing. This could allow measurement of ferritin immediately in the clinic with only a drop of blood, and enable treatment decisions based on these results.